• Journal of Ginseng Research
• /
• v.27 no.3
• /
• pp.115-119
• /
• 2003

There has been continuing interest in the development of synthetic and natural compounds that modify the immune response particularly for the treatment of AIDS and cancer. During the past fifty years, numerous scientific studies have been published on ginseng. Modem human studies have investigated preventive effect of ginseng on several kinds of cancer, its long term immunological effect on HIV patients, its effect on cell mediated immune functions in healthy volunteers. Similarly non clinical studies on animal model system have studied the chemopreventive action of ginseng on cancer and immunological properties of ginseng. The precise mechanism of action of ginseng, however, not clearly understood. Considering its wide-ranging therapeutic effects, this study is being undertaken to elucidate the general mode of action of ginseng, especially to test our hypothesis that its biological action may be mediated by the immune system.

• Proceedings of the Korean Society of Applied Pharmacology
• /
• 2006.11a
• /
• pp.139-145
• /
• 2006

Kaneka Corporation (Kaneka) has been manufacturing CoQ10 under GMP regulation since 1977. Kaneka has a sophisticated quality control system and has been supplying high quality CoQ10 materials to the worldwide customers (Kaneka CoQ10) for about 30 years. Kaneka CoQ10 is characterized by a lot of safety data, which are derived from clinical trials with healthy volunteers (single-dose and 4-week multi-dose safety studies), animal studies (13-week sub-chronic study in dogs and 52-week chronic study in rats), three types of mutagenicity test, six type of skin irritation test (for cosmetics), and others. The risk assessment of CoQ10 was performed by Council for Responsible Nutrition (USA). They reviewed many of available clinical data including clinical trials using Kaneka Q10, and concluded that the upper level for supplements (ULS) of CoQ10 is 1,200 mg/day (Hathcock and Shao. 2006, Regulatory Toxicology and Pharmacology, 45, 282 - 288).

• Journal of the Korean Society of Physical Medicine
• /
• v.6 no.3
• /
• pp.353-360
• /
• 2011

Purpose : The purpose of this study was to compare the effect of muscle strength by stimulation of russian current and low frequency. Methods : The subjects were thirty young healthy volunteers who were divided into two groups including russian current group(n=15) and low frequency group(n=15). The intervention was applied totally 12 times (1 time, 10 minute) for 4weeks in each group. The peak torque and average power were measured and analysed using Biodex system 4 before the treatment, after 2 weeks, 4 weeks. Results : As a result, russians currents and low frequency stimulation increased significantly average power and peak torque with the lapse of time. However, there were not significant differences of the average power and peak torque between the groups in all periods. Conclusion : In conclusion, russians currents and low frequency stimulation had no differences in the increase of muscle strength.

• Journal of Sensor Science and Technology
• /
• v.23 no.6
• /
• pp.357-361
• /
• 2014

This paper describes the evaluation of the effectiveness of rehabilitation therapy for patients with finger paralysis based on a two-finger force measurement system (TFFMS). The paralyzed fingers can be recovered through rehabilitation therapies. The finger pressing force of the patients can be measured utilizing the TFFMS previously developed by the author [7]. The TFFMS, however, has not been fully adopted as a standard method for evaluating the therapy owing to the lack of a standard protocol. The pressing force of healthy volunteers and patients is analyzed with the TFFMS to explore the feasibility of the TFFMS as an evaluation device. The test confirms that the established standard protocol is useful to quantitatively assess the progress of finger rehabilitation therapy.

• Microbiology and Biotechnology Letters
• /
• v.27 no.4
• /
• pp.267-272
• /
• 1999

The effects of Bifidobacterium longum HY8001 supplement intake on the fecal microflora and fecal bacterial enzyme activity were studied in ten healthy human volunteers, before, during and after intake (respectively for 3 weeks). During intake of B. longum HY8001 supplement, fecal, $\beta$-glucuronidase and nitroreductase activities significantly decreased 44.6%(p<0.005) and 32.3%(p<0.01), respectively. Although numbers of major bacterial groups of fecal microflora were not affected by B. longum HY8001 intake for 3 weeks, the number of Bifidobacterium was significantly increased (p<0.05). This result indicates that intake of B. longum HY8001 might be potentially beneficial for the prevention and inhibition of colon cancer and improvement of human intestinal microflora composition.

• Proceedings of the PSK Conference
• /
• 2002.10a
• /
• pp.420.2-421
• /
• 2002

A validated UV determination of loratadine in human plasma was developed and the pharmacokinetic profiles of single dose of loratadine were determined in 8 healthy volunteers. Human serum samples (1.0 mL) spiked with known concentration of loratadine and 50 ng diazepam as an internal standard were alkalinized with 500 ${\mu}\ell$ ${\mu}\ell$ of 10% $Na_{2}CO_{3}$ and extracted with 7 mL of mixture of isopentane and hexane (2 : 1. v/v) for 5 min. Extracts were centrifuged and 6 mL of organic layer was back-extracted with 150 ${\mu}\ell$ of 12.5% $Na_{2}PO_{4}$ for 1 min. (omitted)

• Proceedings of the PSK Conference
• /
• 2003.04a
• /
• pp.311.2-312
• /
• 2003

The purposes of this study were to evaluate bioequivalence (BE) using In-transformed pharmacokinetic parameters obtained from two fluconazole products and to develop the analytical methods for the quantitative determination of fluconazole in human serum. In addition, the in vitro dissolution profiles of the two fluconazole products at dissolution media: 0.1 M hydrochloride (KP Ⅶ Apparatus II method) were assessed. (omitted)

• 한국약용작물학회:학술대회논문집
• /
• 2006.11a
• /
• pp.139-145
• /
• 2006

Kaneka Corporation (Kaneka) has been manufacturing CoQ10 under GMP regulation since 1977. Kaneka has a sophisticated quality control system and has been supplying high quality CoQ10 materials to the worldwide customers (Kaneka CoQ10) for about 30 years. Kaneka CoQ10 is characterized by a lot of safety data, which are derived from clinical trials with healthy volunteers (single-dose and 4-week multi-dose safety studies), animal studies (13-week sub-chronic study in dogs and 52-week chronic study in rats), three types of mutagenicity test, six type of skin irritation test (for cosmetics), and others. The risk assessment of CoQ10 was performed by Council for Responsible Nutrition (USA). They reviewed many of available clinical data including clinical trials using Kaneka Q10, and concluded that the upper level for supplements (ULS) of CoQ10 is 1,200mg/day (Hathcock and Shao. 2006, Regulatory Toxicology and Pharmacology, $\underline{45}$, 282 - 288).

• Speech Sciences
• /
• v.14 no.4
• /
• pp.221-232
• /
• 2007

Topiramate (TPM) is a new antiepileptic drug characterized by a clinical effective reduction in seizure frequency and it represents a useful drug effective in a wide range of epileptic patients. Known side effects are represented by weight loss, hypohidrosis, anorexia, sedation, nephrolithiasis, cognitive complaints and language disorders. This study is to examine acoustic characteristics of patients with TPM. 15 patients were assessed through a Computerized Speech Lab (CSL) applied before the beginning of therapy with TPM and 3 months after medication had been stabilized. Tests had been chosen to assess voice onset time (VOT), total duration (TD), vowel formants, loudness, pitch, speaking rate, and articulation patterns. We compared the data from patients and healthy volunteers. The statistical analysis of the results did not show changes in acoustic tests, except for TD which was increased. The increase of the TD is evaluated as a deterioration of fluency. Our results suggest that patients with TPM did not experience acoustic speech changes except that fluency was declined. Unlike previous studies, the medication of TPM has nothing to do with speech problems in patients with epilepsy.

• Proceedings of the Korean Society of Medical Physics Conference
• /
• 2002.09a
• /
• pp.425-426
• /
• 2002

The bone densitometer is to investigate the bone mineral content and density for the osteoporosis assessment by using dual energy X-ray photons. For the clinical verification of the ISOL's OSTEO plus, the clinical study was performed with healthy and non-menopausal 30 female volunteers. The fan-beam DXA machine (Lunar, Expert) was chosen as a reference. After correlation analysis of their bone mineral densities, a strong correlation was obtained. From the results, it is claimed that the new forearm bone densitometer is clinically useful in osteoporosis diagnosis.